Genetic Signatures | GSS - Operating Profit

Stock Price
0.08
Daily Change
0.004 5.33%
Monthly
-34.17%
Yearly
-84.81%
Q1 Forecast
0.08

Genetic Signatures reported AUD-6.34M in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Avita Medical AUD -10.41M 742K Dec/2025
Medical Developments International AUD -36K 444K Dec/2025
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -8.5M 2.57M Jun/2025
Starpharma Holdings AUD -873K 1.43M Dec/2025
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025